Mankind Pharma Ltd (MANKIND) — Announcement | 31 August 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Mankind Pharma finalizes sale of Broadway Hospitality stake
💡 Investor Takeaway
The divestment simplifies the company's portfolio and exits a non-core hospitality business.

Mankind Pharma announced it has completed the sale of its entire 100% stake in Broadway Hospitality Services Private Limited to AKRK Projects LLP, effective August 31, 2026, removing Broadway from its consolidated group structure.

📄 View Original Announcement (PDF)

About Mankind Pharma Ltd (MANKIND)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹99,077.74 Cr P/E: 48.5 ROE: 12.7% ROCE: 13.9% Div Yield: 0.04%

View full MANKIND stock details →

📡 Get AI alerts when MANKIND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANKIND — Free

📊 More MANKIND filings

See all MANKIND filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MANKIND files new disclosures

Track MANKIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANKIND — Free

Free account · 2 AI queries/day